A randomized placebo-controlled trial of traditional Chinese medicine as an add-on therapy to oral montelukast in the treatment of mild persistent asthma in children
There was significant improvement in ACT™ score in aYPFS group but not in the control group. aYPFS added on to montelukast improved Asthma Control Test Score in children with asthma. There were no significant differences between groups in other primary and secondary outcome parameters.